Evidence map›Paper›PMID 15870186›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2005

Polyclonality of familial murine adenomas: analyses of mouse chimeras with low tumor multiplicity suggest short-range interactions.

Andrew T Thliveris, Richard B Halberg, Linda Clipson, William F Dove, Ruth Sullivan, Mary Kay Washington, Stephen Stanhope, Michael A Newton

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Mutational Heterogeneity inClinical cancer research : an official journal of the American Association for Cancer Research · 2017
    Article
  11. OncogenicGenes & development · 2017
    Article
  12. Article
  13. Article
  14. Article
  15. Transformation of epithelial cells through recruitment leads to polyclonal intestinal tumors.Proceedings of the National Academy of Sciences of the United States of America · 2013
    Article
  16. Article
  17. The many ways to open the gate to colon cancer.Cell cycle (Georgetown, Tex.) · 2012
    Article
  18. Monoallelic silencing and haploinsufficiency in early murine intestinal neoplasms.Proceedings of the National Academy of Sciences of the United States of America · 2012
    Article
  19. Clonal structure of carcinogen-induced intestinal tumors in mice.Cancer prevention research (Philadelphia, Pa.) · 2011
    Article
  20. Stem cells and their implications for colorectal cancer.Nature reviews. Gastroenterology & hepatology · 2011
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 3 countries.

Andrew T ThliverisMcArdle Laboratory for Cancer Research, Department of Ophthalmology and Visual Sciences, University of Wisconsin, Madison, WI 53706, USA.
Richard B Halberg
Linda Clipson
William F Dove
Ruth Sullivan
Mary Kay Washington
Stephen Stanhope
Michael A Newton
Vanderbilt University Medical Center · USUniversity of Wisconsin–Madison · US

Funding

GENES CONTROLLING NEOPLASIA OF THE INTESTINAL EPITHELIUMR37CA063677 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI DOVE, WILLIAM FRANKLIN · 1998 to 2008
$6.3M
MOUSE MODELS FOR HUMAN CANCERU01CA084227 · NCI · UNIVERSITY OF WISCONSIN MADISON · PI DOVE, WILLIAM FRANKLIN · 1999 to 2003
$1.9M
STATISTICAL METHODS FOR MOLECULAR CANCER DATAR01CA064364 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI NEWTON, MICHAEL A · 2000 to 2006
$695k
IDENTIFICATION OF MODIFIER GENES AFFECTING NEOPLASIAK08CA084146 · NCI · UNIVERSITY OF WISCONSIN MADISON · PI THLIVERIS, ANDREW T · 2000 to 2004
$559k
NCI NIH HHS K08 CA084146NCI NIH HHS K08CA84146NCI NIH HHS R01 CA064364NCI NIH HHS R01CA64364NCI NIH HHS R37 CA063677NCI NIH HHS R37CA63677NCI NIH HHS U01CA84227
6 · The paper itself

Abstract

In previous studies demonstrating the polyclonal structure of familial intestinal adenomas, high tumor multiplicity made it difficult to eliminate the possibility that polyclonality arose by the random collision of distinct initiated clones as opposed to some form of clonal interaction. We sought to test further the random collision hypothesis. Chimeric mice carrying the multiple intestinal neoplasia (Min) mutation of the adenomatous polyposis coli gene (Apc) and homozygous for the tumor resistance allele of the Mom1 locus were established. These chimeras also display a strong propensity for tumors of polyclonal structure, despite their markedly reduced tumor multiplicity. Considering tumor sizes and multiplicities, the observed fraction of overtly polyclonal heterotypic adenomas was significantly higher than predicted by the random collision hypothesis. This finding supports models of polyclonality involving interaction among multiple initiated clones. The extent of clonal interaction was assessed by statistical analyses that relate the observed frequency of overtly polyclonal heterotypic tumors to the geometry of the chimeric patches and the pattern of underlying crypts. These statistical calculations indicate that the familial adenomas of the Apc(Min/+) mouse may commonly form through interactions between clones as close as 1-2 crypt diameters apart.

Indexed as

Genes, APCAdenomaAdenomatous Polyposis ColiAdenomatous Polyposis Coli ProteinAllelesAnimalsChimeraComputational BiologyCrosses, GeneticDisease ProgressionHomozygoteImmunohistochemistryMiceMice, TransgenicModels, GeneticModels, MolecularAdenomatous Polyposis Coli Protein

Identifiers

PMID15870186
PMCPMC1100801
OpenAlexW2170960037

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.